alexa Causes And Outcome Of Stevens-Johnson Syndrome In Children Presenting To A Tertiary Care Center
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

9th World Dermatology & Pediatric Dermatology Congress
October 10-11, 2016 Manchester, UK

Arshalooz J Rahman, Saadia Tabassum, Farwa Ayub and Ambreen Sonawala
Aga Khan University Hospital, Pakistan
ScientificTracks Abstracts: J Clin Exp Dermatol Res
DOI: 10.4172/2155-9554.C1.041
Background & Aim: Stevens-Johnson syndrome (SJS) is one of the most dreaded drug related complication leading to extensive mucocutaneous involvement in severe cases and long term complications. This group of disease is related to certain medication groups however we report a substantial number of non-drug related cases as well. The aim of this study was to look into various causes and outcome of SJS in children presenting to our institute. Method: A 10 year retrospective review was done on all the cases coming to the Aga Khan University Hospital, variables like etiology, clinical characteristic, treatment and outcome were entered on a predesigned profoma and frequencies were analyzed on SPSS 17. Results: Total sample size of 97 patients was analyzed; 69 patients presented with generalized rash (more than 10% of body involvement with mucositis) and 12 had localized disease (less than 10% skin involvement) 16 patents were categorized as in between category. Exposure to drugs 77 (79.4%), 20 (20.6%) cases were categorized as non-drug related. Out of drug group 52% were exposed to antibiotics, 22% were given antimalarial and 10.5% were given antiepileptic medication. Among the therapeutic interventions intravenous steroids were given 30%, IVIG 2% either alone or in combination rest were managed with supportive care. 23.7% developed systemic complications (AKI 12.6%, sepsis 46%, Pneumonia 13%, and one case developed ocular complication while in hospital. Outcome was classified at the dime of discharge fully resolved 10.6%, partial resolution 71%, mortality 14.4%. Conclusion: Drug related dermal complications like SJS are predominantly attributed to antibiotics, antimalarial and antiepileptic drugs however non drug related presentations also contribute to significant number of cases. Delay in recognition leads to systemic complications morbidity and mortality if not treated on time.

Arshalooz J Rahman is a graduate of Dow Medical College Karachi, Pakistan. She has completed her Residency from Brookdale University Hospital in Pediatrics and Fellowship in Clinical Pediatric Nephrology from Stony Brook University Hospital, USA and Diploma in Health Professional Education from Aga Khan University. She is Diplomate American Board of Pediatrics and presently working at The Aga Khan University Hospital in the Department of Pediatrics and Child Health. Her clinical and academic interest is in general pediatrics, pediatric nephrology and medical education. She is the Training Supervisor for FCPS and MRCP candidates at her institute and Examiner for postgraduates at College of Physicians and Surgeons, Pakistan.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version